1 Min Read
Aug 8 (Reuters) - Immunovaccine Inc:
* Immunovaccine announces financial results for quarter ended June 30, 2017
* Q2 basic loss per share c$0.02 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.